News & Press Releases

Mintz represented G1 Therapeutics, Inc. in its initial public offering of 7,781,564 shares of common stock. G1 Therapeutics is a clinical-stage biopharmaceutical company.

Randy Jones, a Member in the Mintz San Diego office, and Heather Silver, an Associate, authored this LawInSport article on an ongoing controversy involving fraud and academic dishonesty at the University of North Carolina at Chapel Hill among its student-athletes.

Matthew Howsare, a Member in the Mintz Washington, D.C. office and Co-chair of the firm’s Consumer Product Safety Practice, was featured in this ICIX article on the large fines issued by the Consumer Product Safety Commission (CPSC) to major companies for preventable mistakes.

The 2017 Chambers USA: America's Leading Lawyers for Business guide ha recognized 49 Mintz attorneys as “Leaders in Their Fields.” Practice highlights include top rankings for banking and finance.

Mintz has elevated five attorneys to Members of the firm. “These attorneys consistently demonstrate excellence in the delivery of legal services to the firm’s clients,” said Bob Bodian, Managing Member.

Chuck Samuels, a Member in the Mintz Washington, D.C. office, was quoted in a Bloomberg BNA article covering the $2 million budget cut facing the Consumer Product Safety Commission (CPSC) under President Trump’s Fiscal Year 2018 budget proposal.